key: cord-0717677-f8hgcngj authors: Patel, Anita; Jernigan, Daniel B. title: Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020 date: 2020-02-24 journal: Am J Transplant DOI: 10.1111/ajt.15805 sha: 45a2c924ac1eb041b626b90e18e4048e0d675a12 doc_id: 717677 cord_uid: f8hgcngj This article summarizes what is currently known about the 2019 novel coronavirus and offers interim guidance. has not yet been determined. Person-to-person spread is evident; 7 however, how easily the virus is transmitted between persons is currently unclear. 2019-nCoV is similar to coronaviruses that cause MERS and SARS, which are transmitted mainly by respiratory droplets. Signs and symptoms of patients with confirmed 2019-nCoV infection include fever, cough, and shortness of breath. 8 Based on the incubation period of illness from MERS and SARS No claim to original US government works. © 2020 The American Society of Transplantation and the American Society of Transplant Surgeons coronaviruses, CDC believes that symptoms of 2019-nCoV infection occur within 2 to 14 days following infection. Preliminary information suggests that older adults and persons with underlying health conditions or compromised immune systems might be at higher risk for severe illness from this virus 9 ; however, many characteristics of this novel coronavirus and how it might affect individual persons and potentially vulnerable population subgroups, such as the elderly or those with chronic health conditions, remain unclear. On January 21, 2020, the first person in the United States with Nine of the first 11 US 2019-nCoV patients were exposed in Wuhan, China. CDC expects more US cases. Once isolated, the virus will be made available through BEI Resources (https ://www.beire sourc es.org/) to assist research efforts. The 2019-nCoV has impacted multiple countries, caused severe illness, and sustained person-to-person transmission making it a concerning and serious public health threat. It is unclear how this virus will impact the US over time. For the general population, who are unlikely to be exposed to this virus at the current time, the immediate World Health Organization World Health Organization Proclamation on suspension of entry as immigrants and nonimmigrants of persons who pose a risk of transmitting 2019 novel coronavirus Updated preparedness and response framework for influenza pandemics Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2019-20 influenza season potential conflicts of interest. No potential conflicts of interest were disclosed. * Includes any of the following: dyspnea, respiratory rate > 30 breaths per minute, hypoxemia, or chest x-ray with multilobar infiltrates or > 50% progression of pulmonary infiltration within 24-48 hours per WHO. https ://www.who.int/docs/defau lt-sourc e/coron aviru se/situa tion-repor ts/20200 123-sitrep-3-2019-ncov.pdf. † https ://www.who.int/news-room/detai l/30-01-2020-state ment-onthe-second-meeti ng-of-the-inter natio nal-health-regul ations-(2005)emerg ency-commi ttee-regar ding-the-outbr eak-of-novel-coron a virus-(2019-ncov). § https ://www.phe.gov/emerg ency/news/healt hacti ons/phe/Pages/ 2019-nCoV.aspx. ¶ Criteria to guide evaluation and testing of patients under investigation for 2019-nCoV include 1) fever or signs or symptoms of lower respiratory tract illness (eg, cough or shortness of breath) in any person, including a health care worker, who has had close contact with a patient with laboratory-confirmed 2019-nCoV infection within 14 days of symptom onset; 2) fever and signs or symptoms of lower respiratory tract illness (eg, cough or shortness of breath) in any person with a history of travel from Hubei Province, China, within 14 days of symptom onset; or 3) fever and signs or symptoms of lower respiratory tract illness (eg, cough or shortness of breath) requiring hospitalization in any person with a history of travel from mainland China within 14 days of symptom onset. More information is available at https ://emerg ency.cdc.gov/han/han00 427.asp and https ://emerg ency.cdc.gov/han/han00 426.asp. **https ://wwwnc.cdc.gov/trave l/notic es/warni ng/novel-coron avirus-china . † † https ://www.cdc.gov/media/ relea ses/2020/p0117-coron avirusscree ning.html. § § CDC's initial health screening includes a measurement of each traveler's temperature with a handheld noncontact thermometer, observation of these travelers for visible signs of respiratory illness (eg, cough or difficulty breathing), and review of symptoms through a self-administered questionnaire. ¶ ¶ The more comprehensive public health assessment determines, based on the traveler's illness and exposure, whether the traveler should be taken to a hospital for further medical evaluation and care, which might include testing for 2019-nCoV. ***https ://www.cdc.gov/coron aviru s/2019-ncov/trave lers/commu nica t ion-resou rces.html. † † † https ://emerg ency.cdc.gov/han/han00 427.asp. § § § https ://emerg ency.cdc.gov/coca/calls/ 2020/calli nfo_013120.asp. ¶ ¶ ¶ Close contact is defined as 1) being within approximately 6 ft (2 m) of a 2019-nCoV patient for a prolonged period while not wearing recommended personal protective equipment (PPE) (eg, gowns, gloves, National Institute for Occupational Safety and Health-certified disposable N95 respirator, and eye protection); close contact can occur while caring for, living with, visiting, or sharing a health care waiting area or room with a 2019-nCoV patient; or 2) having direct contact with infectious secretions of a 2019-nCoV patient (eg, being coughed on) while not wearing recommended PPE. ****https ://www.cdc.gov/coron aviru s/2019-nCoV/lab/guide linesclini cal-speci mens.html.